Matinas BioPharma
MTNB
#10329
Rank
A$4.45 M
Marketcap
$0.88
Share price
-3.64%
Change (1 day)
-94.58%
Change (1 year)

Matinas BioPharma (MTNB) - Total debt

Total debt on the balance sheet as of September 2024 : A$5.07 Million

According to Matinas BioPharma's latest financial reports the company's total debt is A$5.07 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Matinas BioPharma - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$5.21 M-13.87%
2022-12-31A$6.06 M-6.58%
2021-12-31A$6.48 M33.01%
2020-12-31A$4.87 M-19.25%
2019-12-31A$6.03 M988.86%
2018-12-31A$0.55 M63.47%
2017-12-31A$0.33 M69.34%
2016-12-31A$0.2 M1196.19%
2015-12-31A$0.01 M-78.79%
2014-12-31A$0.07 M
2013-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$5.26 M 3.65%๐Ÿ‡บ๐Ÿ‡ธ USA